Bayforest Capital’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$125K Buy
+1,465
New +$153K 0.19% 183

Other funds holding MIRM

Bayforest Capital's MIRM Position: Q3 2026 in Review

Bayforest Capital opened a new position in Mirum Pharmaceuticals (MIRM) in Q3 2026: 1,465 shares worth $125K. The stake represents 0.19% of the portfolio and ranks #183 among its holdings.

317 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Bayforest Capital held 1,465 shares of Mirum Pharmaceuticals worth $125K as of Q3 2026.
  • Mirum Pharmaceuticals was a new Bayforest Capital position in Q3 2026.
  • Mirum Pharmaceuticals made up 0.19% of Bayforest Capital's portfolio in Q3 2026, its #183 holding.
  • 317 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Bayforest Capital's 13F filing for Q3 2026, filed 3 Nov 2026.